Huojian Shen

413 citations
9 papers · 264 indexed · h-index 7
Topics
Cancer Cells and Metastasis (2 papers)Peptidase Inhibition and Analysis (2 papers)Gallbladder and Bile Duct Disorders (2 papers)
Partner nations
China

In The Last Decade

Huojian Shen

9 papers receiving 261 citations

Peers

Huojian Shen
Comparison fields: 5 of 45
  • Surgery 137
  • Pulmonary and Respiratory Medicine 125
  • Molecular Biology 113
  • Cancer Research 77
  • Oncology 59
Replace Yuan Chu with:
Yuan Chu China
Elvira Buxó Spain
Takashi Kiyokawa Japan
Kei Daizumoto Japan
Chengpeng Gui China
Baoxing Jia China
Yusuke Shimodaira United States
Andrea Sagnotta Italy
Zechao Lu China
Christina Schleicher Germany
Huojian Shen relative to Yuan Chu China Yuan Chu's profile →
Citations per field
00.5×1.5×
Yuan Chu · 1×
Citations per year

Countries citing papers authored by Huojian Shen

Since Specialization
Citations

This map shows the geographic impact of Huojian Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huojian Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huojian Shen more than expected).

Fields of papers citing papers by Huojian Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huojian Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huojian Shen. The network helps show where Huojian Shen may publish in the future.

Co-authorship network of co-authors of Huojian Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Huojian Shen. A scholar is included among the top collaborators of Huojian Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huojian Shen. Huojian Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1
Tracking of trastuzumab resistance in patients with HER2-positive metastatic gastric cancer by CTC liquid biopsy.
5
2 1
3 42
4 42
5 76
6 47
7
Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
7
8 6
9 38

About Huojian Shen

Huojian Shen is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 264 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (2 papers), Peptidase Inhibition and Analysis (2 papers) and Gallbladder and Bile Duct Disorders (2 papers). The work is most often cited by research in Cancer Research (77 citations), Pulmonary and Respiratory Medicine (125 citations) and Surgery (137 citations). Huojian Shen has collaborated with scholars based in China. Frequent co-authors include Hongyi Zhu, Fu Ji, Chao Yang, Kewei Li, Ming Xu, Li Fu, Zhiyong Shen, Chao‐Chun Yang, Yuanwen Chen and Jie Zhang. Their work appears in journals such as Cell Death and Disease, Pediatric Surgery International and Asian Pacific Journal of Cancer Prevention.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026